Short answer
Corcept Therapeutics Inc (CORT) filed its Q3 2026 10-Q quarterly report on Nov 3, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $340M (up 64.0% year over year) with net income of $127M.
Q3 2026 key financials · XBRL
- Revenue
- $340M
- +64.0% YoY · +32.9% QoQ
- Net income
- $127M
- +544.6% YoY · +194.9% QoQ
- Operating margin
- 33.7%
- EPS (diluted)
- $1.04
- +550.0% YoY · +166.7% QoQ
Source: XBRL data from the Corcept Therapeutics Inc (CORT) Q3 2026 10-Q on SEC EDGAR. USD.
Corcept Therapeutics Inc Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $340.5M, up 64.0% YoY from $207.6M, driven by Hypercortisolism Products and Lifyorli
- Hypercortisolism Products revenue $249.1M, up from $207.6M; Lifyorli generated $91.4M after April launch
- Cost-of-sales margin 98.6% vs 97.8% YoY, with cost of sales 1.4% vs 2.2% of revenue
- Cash, equivalents and marketable securities $662.3M vs $532.4M; operating cash flow $159.7M vs $103.5M
- 2026 outlook: R&D expense approximately unchanged; SG&A higher, IRA may reduce profits in 2026 and beyond
Risk Factors
- New FDA relacorilant review risk: December 30, 2025 CRL triggered additional analyses and NDA resubmission
- New regulatory risk: HHS re-examination of mifepristone safety announced September 2025
- Competitive risk: Teva’s generic mifepristone materially reduced Hypercortisolism Product pricing
- Operational concentration: Curant collects payments from insurers representing more than 99% of hypercortisolism revenue
- Financial risk: OBBBA Medicaid funding cuts may increase patient-assistance costs and reduce product access
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Corcept Therapeutics Inc quarterly reports
- Q3 2019 10-QFiled Nov 7, 2019
- Q2 2019 10-QFiled Aug 1, 2019
- Q1 2019 10-QFiled May 9, 2019
- Q3 2018 10-QFiled Nov 2, 2018
- Q2 2018 10-QFiled Aug 9, 2018
- Q1 2018 10-QFiled May 9, 2018
- Q3 2017 10-QFiled Nov 3, 2017
- Q2 2017 10-QFiled Aug 2, 2017
- Q1 2017 10-QFiled May 2, 2017
- Q3 2016 10-QFiled Nov 2, 2016
- Q2 2016 10-QFiled Aug 3, 2016
- Q1 2016 10-QFiled May 4, 2016
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.